Works matching DE "ZIPRASIDONE"

Results: 207

Prevalence of contraindicated combinations amid behavioral and mental health medications filled in a pediatric population.

Published in:

BMC Primary Care, 2024, v. 25, n. 1, p. 1, doi. 10.1186/s12875-024-02528-9

By:

Borgelt, Laura M.;
Bliss, Kathryn;
Matson, Jacqueline;
Cajuste, Bosede;
Kuang, Xiaoying;
Toohey, Monica;
Pace, Wilson;
Shemesh, Eyal;
Lo, Suzanne;
Olczyk, Anna;
Gleason, Kristine;
Pincus, Harold;
Kleinman, Lawrence C.

Publication type:

Article

Involvement of Cholinergic System in Hyperactivity in Dopamine-Deficient Mice.

Published in:

Neuropsychopharmacology, 2015, v. 40, n. 5, p. 1141, doi. 10.1038/npp.2014.295

By:

Hagino, Yoko;
Kasai, Shinya;
Fujita, Masayo;
Setogawa, Susumu;
Yamaura, Hiroshi;
Yanagihara, Dai;
Hashimoto, Makoto;
Kobayashi, Kazuto;
Meltzer, Herbert Y;
Ikeda, Kazutaka

Publication type:

Article

Genome-Wide Pharmacogenomic Study of Neurocognition As an Indicator of Antipsychotic Treatment Response in Schizophrenia.

Published in:

Neuropsychopharmacology, 2011, v. 36, n. 3, p. 616, doi. 10.1038/npp.2010.193

By:

McClay, Joseph L.;
Adkins, Daniel E.;
Åberg, Karolina;
Bukszár, Jozsef;
Khachane, Amit N.;
Keefe, Richard S. E.;
Perkins, Diana O.;
McEvoy, Joseph P.;
Stroup, T. Scott;
Vann, Robert E.;
Beardsley, Patrick M.;
Lieberman, Jeffrey A.;
Sullivan, Patrick F.;
Van den Oord, Edwin J. C. G.

Publication type:

Article

Lithium-induced acute intermittent dystonia in a patient with schizoaffective disorder.

Published in:

European Psychiatry, 2016, v. 33, p. S671, doi. 10.1016/j.eurpsy.2016.01.1993

By:

Engel, A.;
Bilbruck, T.;
Hossain, S.;
Leahy, R.

Publication type:

Article

Comparative effects of ziprasidone and quetiapine on sleep physiology measures in patients with major depressive disorder.

Published in:

European Psychiatry, 2016, v. 33, p. S743, doi. 10.1016/j.eurpsy.2016.01.2219

By:

Miljatovic, A.

Publication type:

Article

Ziprasidone Associated Sexual Hyperarousal: a Case Report.

Published in:

European Psychiatry, 2015, v. 30, p. 930, doi. 10.1016/S0924-9338(15)30728-8

By:

Kocakaya, H.;
Celikbas, Z.;
Yildiz, M.;
Songur, E.;
Batmaz, S.

Publication type:

Article

Pharmacogenetics of Adverse Events in Schizophrenia Treatment: Comparison Study of Ziprasidone, Olanzapine and Perazine.

Published in:

European Psychiatry, 2015, v. 30, p. 1680, doi. 10.1016/S0924-9338(15)31287-6

By:

Tybura, P.;
Trzesniowska-Drukala, B.;
Samochowiec, J.

Publication type:

Article

New Treatment Strategies of Dissociative Symptoms in Bipolar Disorder: Three Case Report with Literature Review.

Published in:

European Psychiatry, 2015, v. 30, p. 549, doi. 10.1016/S0924-9338(15)30433-8

By:

Preve, M.;
Mula, M.;
Godio, M.;
Suardi, N.;
Traber, R.;
Colombo, R.

Publication type:

Article

Neurocognitive effectiveness of quetiapine, olanzapine, risperidone, and ziprasidone: A pragmatic, randomized trial

Published in:

European Psychiatry, 2013, v. 28, n. 3, p. 174, doi. 10.1016/j.eurpsy.2011.10.003

By:

Johnsen, E.;
Jørgensen, H.A.;
Kroken, R.A.;
Løberg, E.-M.

Publication type:

Article

2839 – Ziprasidone augmentation of lamotrigine in treatment depersonalization in bipolar disorder.

Published in:

2013

By:

Preve, M.;
Mula, M.;
Favaretto, E.;
Basaglia, C.;
Schwitzer, J.

Publication type:

Abstract

2283 – Safety and tolerability of aripiprazole once-monthly initiated in adults with schizophrenia stabilized on atypical oral antipsychotics other than aripiprazole.

Published in:

2013

By:

Potkin, S.;
Raoufinia, A.;
Mallikaarjun, S.;
Bricmont, P.;
Peters-Strickland, T.;
Kasper, W.;
Jin, N.;
Baker, R.A.;
Eramo, A.;
Sanchez, R.;
McQuade, R.D.

Publication type:

Abstract

1403 – Hyperprolactinemia and antipsychotic use in psychiatric patients.

Published in:

2013

By:

Carvalho, M.;
Góis, C.

Publication type:

Abstract

P-1081 - The effects of metoprolol and diltiazem in prolonged QTc interval caused by ziprasidone injection in rats

Published in:

2012

By:

Erbas, O.

Publication type:

Abstract

P-1098 - Ziprasidone as adjunctive therapy in patients with schizoaffective or bipolar disorder treated with clozapine

Published in:

2012

By:

Benvenuti, A.;
Lattanzi, L.;
Bartolommei, N.;
Luchini, F.;
Cosentino, L.;
Mauri, M.

Publication type:

Abstract

Use of ziprasidone in patients with schizophrenia in four European countries

Published in:

European Psychiatry, 2011, v. 26, n. 1, p. 29, doi. 10.1016/S0924-9338(11)71711-4

By:

Montes, J.-M.

Publication type:

Article

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia.

Published in:

Indian Journal of Psychiatry, 2012, v. 54, n. 3, p. 248, doi. 10.4103/0019-5545.102425

By:

Shrivastava, Amresh;
Johnston, Megan;
Terpstra, Kristen;
Stitt, Larry;
Shah, Nilesh

Publication type:

Article

Neuroprotective effect of ziprasidone: Preliminary results compared to haloperidol.

Published in:

Journal of Experimental & Clinical Medicine / Deneysel ve Klinik Tip Dergisi, 2014, v. 31, n. 2, p. 71, doi. 10.5835/jecm.omu.31.02.002

By:

Çınar, Nilgün;
Karaoğlan, Alper;
Midi, Ahmet;
Çal, Mehmet Alpay;
Kelten, Bilal;
Çakmak, Miraç Ayşen;
Şahin, Şevki

Publication type:

Article

Acne caused by ziprasidone in a young patient with bipolar disorder: A case report.

Published in:

Frontiers in Psychiatry, 2022, v. 13, p. 1, doi. 10.3389/fpsyt.2022.948977

By:

Yiwen Yuan;
Xiaoqing Li;
Xingmei Jiang;
Zhixiong Li;
Ying Ou;
Zhe Li

Publication type:

Article

Ziprasidone-induced sub acute cutaneous lupus erythematosus.

Published in:

2017

By:

Codina, M. Quintana;
Vila, L. Creus;
Ninot, G. Melé;
Redonnet, M. Salleras

Publication type:

Case Study

Crystal structure of ziprasidone hydrochloride monohydrate, C21H22Cl2N4OS(H2O).

Published in:

Powder Diffraction, 2015, v. 30, n. 3, p. 192, doi. 10.1017/S0885715615000305

By:

Kaduk, James A.;
Zhong, Kai;
Gindhart, Amy M.;
Blanton, Thomas N.

Publication type:

Article

Patient choice as a driver of medication-switching in non-adherent individuals with bipolar disorder.

Published in:

Patient Preference & Adherence, 2014, v. 8, p. 487, doi. 10.2147/PPA.S56790

By:

Sajatovic, Martha;
Tatsuoka, Curtis;
Dines, Philipp;
Bialko, Christopher S.;
Athey, Melanie;
Williams, Tiffany;
Cassidy, Kristin A

Publication type:

Article

Natural gums as sustained release carriers: development of gastroretentive drug delivery system of ziprasidone HCl.

Published in:

DARU: Journal of Pharmaceutical Sciences, 2012, v. 20, p. 1, doi. 10.1186/2008-2231-20-58

By:

A. J., Rajamma;
H. N., Yogesha;
S. B., Sateesha

Publication type:

Article

Oral ziprasidone in the treatment of patients with bipolar disorders: a critical review.

Published in:

Expert Review of Clinical Pharmacology, 2011, v. 4, n. 2, p. 163, doi. 10.1586/ecp.10.139

By:

Sacchetti, Emilio;
Galluzzo, Alessandro;
Valsecchi, Paolo

Publication type:

Article

Open prospective study of ziprasidone in patients with schizophrenia with depressive symptoms: A multicenter study.

Published in:

Psychiatry & Clinical Neurosciences, 2015, v. 69, n. 1, p. 43, doi. 10.1111/pcn.12212

By:

Jung, Woo‐Young;
Kim, Sung‐Gon;
Lee, Jin‐Seong;
Kang, Dong‐Ho;
Jung, Bong‐Joo;
Shin, Dong‐Hun;
Lee, Young‐Min;
Choi, Sang‐Heon

Publication type:

Article

Anti-leucine-rich glioma-inactivated 1 encephalitis with manic symptoms as the initial manifestation.

Published in:

2018

By:

Tu, Tsung-Han;
Chan, Yee-Lam E.;
Bai, Ya-Mei

Publication type:

Case Study

Comparative effectiveness of switching antipsychotic drug treatment to aripiprazole or ziprasidone for improving metabolic profile and atherogenic dyslipidemia: a 12-month, prospective, open-label study.

Published in:

Journal of Psychopharmacology, 2012, v. 26, n. 9, p. 1201, doi. 10.1177/0269881111430748

By:

Chen, Yuejin;
Bobo, William V;
Watts, Kara;
Jayathilake, Karuna;
Tang, Tinlai;
Meltzer, Herbert Y

Publication type:

Article

Human Hemoglobin and Antipsychotics Clozapine, Ziprasidone and Sertindole: Friends or Foes?

Published in:

International Journal of Molecular Sciences, 2023, v. 24, n. 10, p. 8921, doi. 10.3390/ijms24108921

By:

Platanić Arizanović, Lena;
Gligorijević, Nikola;
Cvijetić, Ilija;
Mijatović, Aleksandar;
Ristivojević, Maja Krstić;
Minić, Simeon;
Kokić, Aleksandra Nikolić;
Miljević, Čedo;
Nikolić, Milan

Publication type:

Article

Is There Room for Second-Generation Antipsychotics in the Pharmacotherapy of Panic Disorder? A Systematic Review Based on PRISMA Guidelines.

Published in:

International Journal of Molecular Sciences, 2016, v. 17, n. 4, p. 551, doi. 10.3390/ijms17040551

By:

Perna, Giampaolo;
Alessandra, Alciati;
Raffaele, Balletta;
Elisa, Mingotto;
Giuseppina, Diaferia;
Paolo, Cavedini;
Maria, Nobile;
Daniela, Caldirola

Publication type:

Article

Ziprasidone suppresses pancreatic adenocarcinoma cell proliferation by targeting GOT1 to trigger glutamine metabolism reprogramming.

Published in:

Journal of Molecular Medicine, 2022, v. 100, n. 4, p. 599, doi. 10.1007/s00109-022-02181-8

By:

Yang, Yueying;
Zheng, Mengzhu;
Han, Fei;
Shang, Lei;
Li, Mingxue;
Gu, Xiaoxia;
Li, Hua;
Chen, Lixia

Publication type:

Article

Cognitive Effects of Reducing First-Generation Antipsychotic Dose Compared to Switching to Ziprasidone in Long-Stay Patients with Schizophrenia.

Published in:

Journal of Clinical Medicine, 2024, v. 13, n. 7, p. 2112, doi. 10.3390/jcm13072112

By:

Bogers, Jan P. A. M.;
Blömer, Jasper A.;
de Haan, Lieuwe

Publication type:

Article

SCHIZOFRENIE V ADOLESCENCI A JEJÍ LÉČBA.

Published in:

Ceská a Slovenská Psychiatrie, 2022, v. 118, n. 4, p. 163

By:

Hrdlička, Michal

Publication type:

Article

Adverse effects of antipsychotics on sleep in patients with schizophrenia. Systematic review and meta-analysis.

Published in:

Frontiers in Psychiatry, 2023, p. 1, doi. 10.3389/fpsyt.2023.1189768

By:

Valencia Carlo, Yarmila Elena;
Saracco-Alvarez, Ricardo Arturo;
Valencia Carlo, Verónica Angela;
Vázquez Vega, Daniela;
Natera Rey, Guillermina;
Escamilla Orozco, Raul Ivan

Publication type:

Article

Physiologically‐based pharmacokinetics of ziprasidone in pregnant women.

Published in:

British Journal of Clinical Pharmacology, 2019, v. 85, n. 5, p. 914, doi. 10.1111/bcp.13872

By:

Biesdorf, Carla;
Martins, Frederico S.;
Sy, Sherwin K.B.;
Diniz, Andrea

Publication type:

Article

Optimal sampling of antipsychotic medicines: a pharmacometric approach for clinical practice.

Published in:

British Journal of Clinical Pharmacology, 2014, v. 78, n. 4, p. 800, doi. 10.1111/bcp.12410

By:

Perera, Vidya;
Bies, Robert R.;
Mo, Gary;
Dolton, Michael J.;
Carr, Vaughan J.;
McLachlan, Andrew J.;
Day, Richard O.;
Polasek, Thomas M.;
Forrest, Alan

Publication type:

Article

Ziprasidone-induced hypersensitivity syndrome confirmed by reintroduction.

Published in:

International Journal of Dermatology, 2014, v. 53, n. 4, p. e267, doi. 10.1111/ijd.12246

By:

Kim, Mi Sun;
Kim, Seo Wan;
Han, Tae Young;
Son, Sook Ja;
Lee, June Hyunkyung;
Kim, Eui‐Joong

Publication type:

Article

REGARDING "A RISPERIDONE-INDUCED PROLACTINOMA RESOLVED WHEN A WOMAN WITH SCHIZOAFFECTIVE DISORDER SWITCHED TO ZIPRASIDONE: A CASE REPORT".

Published in:

2013

By:

Coppola, Danielle;
Thiagarajah, Shanker;
Hong Qiu;
Hough, David;
Arcari, Gail T.;
Mendes, Asante K.;
Sothern, Robert B.

Publication type:

Letter

A Risperidone-Induced Prolactinoma Resolved when a Woman with Schizoaffective Disorder Switched to Ziprasidone: A Case Report.

Published in:

Innovations in Clinical Neuroscience, 2012, v. 9, n. 9, p. 21

By:

Arcari, Gail T.;
Mendes, Asante K.;
Sothern, Robert B.

Publication type:

Article

Evidence for clinicians: Atypical antipsychotics for disruptive behaviour disorders in children and youths.

Published in:

Paediatrics & Child Health (1205-7088), 2019, v. 24, n. 2, p. 125, doi. 10.1093/pch/pxy156

By:

Ortega, Iliana

Publication type:

Article

High-Performance Liquid Chromatographic Assay for Ziprasidone in Plasma Samples: Application to Pharmacokinetic Studies in Rats.

Published in:

Journal of Chromatographic Science, 2012, v. 50, n. 10, p. 902, doi. 10.1093/chromsci/bms088

By:

Marghade, Swapnil;
Musmade, Prashant B.;
Moorkoth, Sudheer

Publication type:

Article

Long-Term Antipsychotic Effectiveness in First Episode of Psychosis: A 3-Year Follow-Up Randomized Clinical Trial Comparing Aripiprazole, Quetiapine, and Ziprasidone.

Published in:

International Journal of Neuropsychopharmacology, 2018, v. 21, n. 12, p. 1090, doi. 10.1093/ijnp/pyy082

By:

Gómez-Revuelta, Marcos;
Pelayo-Terán, José María;
Juncal-Ruiz, María;
Foz, Víctor Ortiz-García de la;
Vázquez-Bourgon, Javier;
González-Pinto, Ana;
Crespo-Facorro, Benedicto

Publication type:

Article

Clozapine is gold standard, but questions remain.

Published in:

International Journal of Neuropsychopharmacology, 2012, v. 15, n. 9, p. 1201, doi. 10.1017/S1461145712000284

By:

Volavka, Jan

Publication type:

Article

Ziprasidone Induces Rabbit Atrium Arrhythmogenesis via Modification of Oxidative Stress and Sodium/Calcium Homeostasis.

Published in:

Biomedicines, 2022, v. 10, n. 5, p. 976, doi. 10.3390/biomedicines10050976

By:

Tai, Buh-Yuan;
Lu, Ming-Kun;
Yang, Hsiang-Yu;
Tsai, Chien-Sung;
Lin, Chih-Yuan

Publication type:

Article

A paired case-control comparison of ziprasidone on visual sustained attention and visual selective attention in patients with paranoid schizophrenia.

Published in:

European Review for Medical & Pharmacological Sciences, 2015, v. 19, n. 16, p. 2952

By:

CHEN, X.;
ZHANG, Z. H.;
SONG, Y.;
YUAN, W.;
LIU, Z. X.;
TANG, M. Q.

Publication type:

Article

A twenty-four-week, open-label study on Ziprasidone's efficacy and influence on glucolipid metabolism in patients with schizophrenia and metabolic disorder.

Published in:

European Review for Medical & Pharmacological Sciences, 2013, v. 17, n. 16, p. 2136

By:

C.-H. LI;
L. SHI;
G.-L. ZHAN;
S.-Z. RAO;
H. ZHANG

Publication type:

Article

Long-term safety of ziprasidone in schizophrenic patients: an open trial.

Published in:

European Review for Medical & Pharmacological Sciences, 2012, v. 16, n. 15, p. 2113

By:

SCIARRETTA, A.;
PIAZZI, G.

Publication type:

Article

Effects of the modified electric convulsive treatment (MECT) on cell factors of schizophrenia.

Published in:

Experimental & Therapeutic Medicine, 2017, v. 13, n. 3, p. 873, doi. 10.3892/etm.2017.4075

By:

YONG-FANG GUO;
HUA-BIN FU;
ZH-YUAN LIU;
WEI LU;
KE-YONG LUO;
HONG-RI ZHU;
WEI-DONG NING;
FENG CHEN;
LI-YU YANG;
XIAO-DONG ZHOU

Publication type:

Article

Inpatient prescribing patterns of long-acting injectables and their oral or short-acting injectable equivalent formulations.

Published in:

Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1140969

By:

Yifei Liu;
Patterson, Mark E.;
Sahil, Suman;
Stoner, Steven C.

Publication type:

Article

Effects of several atypical antipsychotics closapine, sertindole or ziprasidone on hepatic antioxidant enzymes: Possible role in drug-induced liver dysfunction.

Published in:

Journal of Toxicology & Environmental Health: Part A, 2021, v. 84, n. 4, p. 173, doi. 10.1080/15287394.2020.1844827

By:

Platanić Arizanović, Lena;
Nikolić-Kokić, Aleksandra;
Brkljačić, Jelena;
Tatalović, Nikola;
Miler, Marko;
Oreščanin-Dušić, Zorana;
Vidonja Uzelac, Teodora;
Nikolić, Milan;
Milošević, Verica;
Blagojević, Duško;
Spasić, Snežana;
Miljević, Čedo

Publication type:

Article

Effects of antipsychotic drug administration on antioxidative defense enzymes in male rat kidney.

Published in:

Journal of Toxicology & Environmental Health: Part A, 2016, v. 79, n. 20, p. 905, doi. 10.1080/15287394.2016.1201706

By:

Nikolić-Kokić, Aleksandra;
Mijušković, Ana;
Tatalović, Nikola;
Nestorov, Jelena;
Miler, Marko;
Oreščanin-Dušić, Zorana;
Nikolić, Milan;
Milošević, Verica;
Blagojević, Duško;
Spasić, Mihajlo;
Miljević, Čedo

Publication type:

Article

Ziprasidone versus clozapine in the treatment of dually diagnosed (DD) patients with schizophrenia and cannabis use disorders: A randomized study.

Published in:

American Journal on Addictions, 2014, v. 23, n. 3, p. 308, doi. 10.1111/j.1521-0391.2014.12126.x

By:

Schnell, Thomas;
Koethe, Dagmar;
Krasnianski, Anna;
Gairing, Stefanie;
Schnell, Knut;
Daumann, Jörg;
Gouzoulis‐Mayfrank, Euphrosyne

Publication type:

Article